• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Pghl Share Price

    Procter & Gamble Health Share PriceProcter & Gamble Health

    Mid Cap 5k Result
    ₹5112.9
    2.8 (0.05%)
    As on 30 September, 2023 | 16:04 BSE: 500126 NSE: PGHLISIN: INE199A01012

    Procter & Gamble Health Performance

    Day Range

    • Low 5064.65
    • High 5135.7
    5112.9

    52 Week Range

    • Low 3870.1
    • High 5500
    5112.9
    • Open Price5134.65
    • Previous Close5110.1
    • Volume3091

    Start SIP in Procter & Gamble Health

    Start SIP

    Procter & Gamble Health Share Price

    • Over 1 Month 7%
    • Over 3 Month -1.54%
    • Over 6 Month 11.84%
    • Over 1 Year 27.71%

    Procter & Gamble Health Key Statistics

    P/E Ratio 37
    PEG Ratio 1.9
    Market Cap Cr 8,487
    Price to Book Ratio 11.3
    EPS 138.2
    Dividend 1.1
    Relative Strength Index 55.66
    Money Flow Index 63.27
    MACD Signal -40.5
    Average True Range 135.78

    Procter & Gamble Health Investment Rating

    • Master Rating:

    • Procter & Gamble Health has an operating revenue of Rs. 1,229.62 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 26% is great, ROE of 30% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Procter & Gamble Health Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 301321310298296268
    Operating Expenses Qtr Cr 256243200207236199
    Operating Profit Qtr Cr 4580110915969
    Depreciation Qtr Cr 6610776
    Interest Qtr Cr 000000
    Tax Qtr Cr 141928231314
    Net Profit Qtr Cr 305977644151
    IndicatorJun 2023Jun 2022
    Total Revenue Annual Cr 1,2481,128
    Operating Expenses Annual Cr 906847
    Operating Profit Annual in Cr 324268
    Depreciation Cr 2727
    Interest Annual Cr 10
    Tax Annual Cr 8561
    Net Profit Annual Cr 229193
    IndicatorJun 2023Jun 2022
    Cash from Operating Activity Annual Cr 170
    Cash from Investing Activity Annual Cr -26
    Cash from Financing Annual Activity Cr -289
    Net Cash Flow Annual Cr -145
    IndicatorJun 2023Jun 2022
    Total ShareHolders Funds Annual Cr 751616
    Fixed Assets Annual Cr 176152
    Total Non Current Assets Annual Cr 305280
    Total Current Assets Annual Cr 796614
    Total Assets Annual Cr 1,101894
    IndicatorJun 2023Jun 2022
    Book Value Per Share Annual Rs 452371
    ROE Annual % 3131
    ROCE Annual % 4039
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2825
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorJun 2023Jun 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorJun 2023Jun 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorJun 2023Jun 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorJun 2023Jun 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %

    Procter & Gamble Health Technicals

    EMA & SMA

    Current Price
    ₹5112.9
    2.8 (0.05%)
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹5026.4
    • 50 Day
    • ₹5071.09
    • 100 Day
    • ₹5033.89
    • 200 Day
    • ₹4889.87
    • 20 Day
    • ₹5009.81
    • 50 Day
    • ₹5132.69
    • 100 Day
    • ₹5115.67
    • 200 Day
    • ₹4810.17

    Procter & Gamble Health Resistance and Support

    PIVOT
    ₹5104.42
    Resistance
    First Resistance ₹5144.19
    Second Resistance ₹5175.47
    Third Resistance ₹5215.24
    RSI 55.66
    MFI 63.27
    MACD Single Line -40.5
    MACD -17.59
    Support
    First Resistance ₹5073.14
    Second Resistance ₹5033.37
    Third Resistance ₹5002.09

    Procter & Gamble Health Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 3,770 212,590 56.39
    Week 11,071 625,057 56.46
    1 Month 12,279 750,969 61.16
    6 Month 11,470 697,948 60.85

    Procter & Gamble Health Result Highlights

    Procter & Gamble Health Synopsis

    NSE-Medical-Generic Drugs

    P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1229.62 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2023. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
    Market Cap 8,487
    Sales 1,230
    Shares in Float 0.80
    No of funds 134
    Yield 1.86
    Book Value 11.3
    U/D Vol ratio 1.1
    LTDebt / Equity
    Alpha 0.1
    Beta 0.15

    Procter & Gamble Health

    Owner NameJun-23Mar-23Dec-22Sep-22
    Promoters 51.82%51.82%51.82%51.82%
    Mutual Funds 8.1%7.34%7.28%6.9%
    Insurance Companies 4.08%4.87%5.11%5.66%
    Foreign Portfolio Investors 7.15%6.72%6.33%6.05%
    Financial Institutions/ Banks
    Individual Investors 23.64%24.09%24.32%24.46%
    Others 5.21%5.16%5.14%5.11%

    Procter & Gamble Health Management

    Name Designation
    Mr. Suresh Talwar Chairman & Ind.Director
    Mr. Milind Thatte Managing Director
    Mr. Amit Gupta Executive Director & CFO
    Mr. Aalok Agrawal Non Executive Director
    Dr. Elizabeth Desmond Non Executive Director
    Mrs. Rani Jadhav Independent Director
    Mr. S Madhavan Independent Director
    Mr. Lokesh Chandak Director
    Mr. Seema Sambasivan Director

    Procter & Gamble Health Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Procter & Gamble Health Corporate Action

    Date Purpose Remarks
    2023-11-03 Quarterly Results
    2023-08-23 Audited Results & Final Dividend
    2023-05-15 Quarterly Results
    2023-02-05 Quarterly Results & Interim Dividend
    2022-11-11 Quarterly Results (Revised) per share(4160%)Special Dividend
    Date Purpose Remarks
    2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
    2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

    Procter & Gamble Health MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 36540
    HDFC Small Cap Fund Growth 22560
    Aditya Birla Sun Life MNC Fund Payout Inc Dist cum Cap Wdrl 3462
    UTI MNC Fund Regular Plan Growth 2610
    Sundaram Small Cap Fund - Regular Plan - Growth Option 2582
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Procter & Gamble Health FAQs

    What is Share Price of Procter & Gamble Health ?

    Procter & Gamble Health share price is ₹5112 As on 30 September, 2023 | 15:50

    What is the Market Cap of Procter & Gamble Health ?

    The Market Cap of Procter & Gamble Health is ₹8487.1 Cr As on 30 September, 2023 | 15:50

    What is the P/E ratio of Procter & Gamble Health ?

    The P/E ratio of Procter & Gamble Health is 37 As on 30 September, 2023 | 15:50

    What is the PB ratio of Procter & Gamble Health ?

    The PB ratio of Procter & Gamble Health is 11.3 As on 30 September, 2023 | 15:50

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.